Literature DB >> 6463032

European collaborative study on prenatal diagnosis: mosaicism, pseudomosaicism and single abnormal cells in amniotic fluid cell cultures.

T H Bui, L Iselius, J Lindsten.   

Abstract

A report is given of the results of a European collaborative study on mosaicism, pseudomosaicism and single abnormal cells in amniotic fluid cell cultures. The mean frequency of cases with mosaicism was 0.10 per cent, with pseudomosaicism 0.64 per cent and with single abnormal cells 2.83 per cent in a series of 44 170 amniotic fluid samples. There was no significant difference between the colony (in situ) and the flask method with regard to the frequency of mosaicism. Pseudomosaicism and single abnormal cells were more frequent in cases studied with the flask method probably due to other factors than the method of cultivation of the cells. The frequency of maternal cell contamination was 0.17 per cent and the frequency of wrong sex assignment was 0.11 per cent. A more correct estimation is obtained if these frequencies are doubled. There was a considerable variation between laboratories with regard to the frequencies given above. One reason for this variation is that there are no sharp limits between mosaicism, pseudomosaicism and single abnormal cells. Thus the material contained cases diagnosed as having pseudomosaicism which turned out to be mosaics at birth and to have an abnormal phenotype. These cases were very rare but pose a definite problem in prenatal cytogenetic diagnosis.

Mesh:

Year:  1984        PMID: 6463032     DOI: 10.1002/pd.1970040710

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  9 in total

1.  The phenotype of 45,X/46,XY mosaicism: an analysis of 92 prenatally diagnosed cases.

Authors:  H J Chang; R D Clark; H Bachman
Journal:  Am J Hum Genet       Date:  1990-01       Impact factor: 11.025

2.  Confined chorionic mosaicism in prenatal diagnosis.

Authors:  D K Kalousek; F J Dill; T Pantzar; B C McGillivray; S L Yong; R D Wilson
Journal:  Hum Genet       Date:  1987-10       Impact factor: 4.132

3.  Asymmetry and skin pigmentary anomalies in chromosome mosaicism.

Authors:  C G Woods; A Bankier; J Curry; L J Sheffield; S F Slaney; K Smith; L Voullaire; D Wellesley
Journal:  J Med Genet       Date:  1994-09       Impact factor: 6.318

4.  Maternal cell contamination in amniotic fluid samples as a consequence of the sampling technique.

Authors:  S Nuss; D Brebaum; C Grond-Ginsbach
Journal:  Hum Genet       Date:  1994-02       Impact factor: 4.132

5.  Prenatal diagnosis of mosaic trisomy 2 and literature review.

Authors:  Ting Wang; Jufei Lian; Congmian Ren; Huamei Huang; Yanlin Huang; Ling Xu; Laiping Zheng; Chanhui Cai; Li Guo
Journal:  Mol Cytogenet       Date:  2020-08-25       Impact factor: 2.009

6.  Comparison of chromosomal instability of human amniocytes in primary and long-term cultures in AmnioMAX II and DMEM media: A cross-sectional study.

Authors:  Seyed Mehdi Hoseini; Fateme Montazeri; Maryam Moghaddam-Matin; Ahmad Reza Bahrami; Hassan Heidarian Meimandi; Saeed Ghasemi-Esmailabad; Seyed Mehdi Kalantar
Journal:  Int J Reprod Biomed       Date:  2020-10-13

7.  Detection of maternal cell contamination in amniotic fluid cell cultures using fluorescent labelled microsatellites.

Authors:  G W Smith; C A Graham; J Nevin; N C Nevin
Journal:  J Med Genet       Date:  1995-01       Impact factor: 6.318

8.  Complex genetic counseling and exclusion of Duchenne muscular dystrophy in a twin pregnancy after in vitro fertilization (IVF).

Authors:  T H Bui; M Anvret; N Dahl; L Garoff; P Sjöblom; T Hillensjö
Journal:  J Assist Reprod Genet       Date:  1994-03       Impact factor: 3.412

9.  The application of an in situ karyotyping technique for mesenchymal stromal cells: a validation and comparison study with classical G-banding.

Authors:  Sang Mee Hwang; Cha-Ja See; Jungeun Choi; Seon Young Kim; Qute Choi; Jung Ah Kim; Jiseok Kwon; Si Nae Park; Kyongok Im; Il-Hoan Oh; Dong Soon Lee
Journal:  Exp Mol Med       Date:  2013-12-20       Impact factor: 8.718

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.